Whilst TP53 mutations are present in up to 15% of SMZL cases, concomitant with del(17p) in most cases, other genes are also recurrently mutation that are implicated in cell cycle control, such as CCND3 (5%) and ATM (4%) [29, 107]. Here, TP53 is linked to splenic marginal zone lymphoma.